Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Healthcare Specialty Enzymes Market Size, Trends, Analysis, and Outlook By Product (Carbohydrases, Polymerases and Nucleases, Proteases, Lipases, Phosphatases/Phytases, Others), By Source (Micro-organisms, Animals, Plants), By Technique (Clinical Chemistry, Immunodiagnostics/Immunoassays, Molecular Diagnostics, Hematology, Microbiology), By Usage (Research & Biotechnology, Diagnosis), By Application (Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases), By End-User (Hospitals, Laboratory, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Research & Biotechnology, Diagnosis), By Application (Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases), By End-User (Hospitals, Laboratory, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Healthcare Specialty Enzymes market size is poised ... Read More
-
Immunoprotein Diagnostic Testing Market Size, Trends, Analysis, and Outlook By Test (Complement System Proteins Diagnostic Tests, Free Light Chain Diagnostic Tests, Haptoglobin Diagnostic Tests, Immunoglobulin Diagnostic Tests, Prealbumin Diagnostic Tests, C-Reactive Protein (CRP) Diagnostic Tests), By Application (Infectious Disease Testing , Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing, Autoimmune Disease Testing), By Technology (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay, Immunoprotein Electrophoresis), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Infectious Disease Testing , Oncology Testing, Endocrine Testing, Toxicology Testing, Allergy Testing, Autoimmune Disease Testing), By Technology (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay, Immunoprotein Electrophoresis), by Region, Country, Segment, ... Read More
-
Point of Care Diagnostics Market Size, Trends, Analysis, and Outlook By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030
... Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030 The global Point ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency Diseases
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Systematic Lupus Erythematosus Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Lupus Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Subcutaneous Immunoglobulins
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Systemic Lupus Erythematosus (SLE) Drugs
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Immunoglobulins
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Systemic Lupus Erythematosus
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency Disease Tests
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Plasma Fractionation of Intravenous Immunoglobulins
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Lupus Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulins
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Monocyte Activation Test Kits
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Cell Therapy Market Report by Cell Type (Stem Cell, Non-stem Cell), Therapy Type (Autologous, Allogeneic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), End User (Hospitals and Clinics, Academic and Research Institutes), and Region 2024-2032
... Region 2024-2032 The global cell therapy market size reached US$ 13.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.5 Billion by 2032, exhibiting a growth rate (CAGR) of 15.28% ... Read More
-
In Vitro Diagnostics Market Report by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Others), Product (Reagents and Kits, Instruments), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, and Others), and Region 2024-2032
... Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, and Others), and Region 2024-2032 The global in vitro diagnostics market size reached US$ 110.9 Billion in 2023. Looking ... Read More
-
Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034
... of care that involves the prescription of riluzole has been effective in slowing the disease progression, thereby increasing the life span of patients. The most recent development in ALS was the addition of RELYVRIO for ... Read More
-
Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034
... common among adults, with a peak incidence between 50 and 70 years. The median age at onset is 52 years. As per the secondary research, the prevalence of wAIHA is 1 per 8,000, and accounts ... Read More
-
Global Interleukin Industry Research Report Growth Trends and Competitive Analysis 2024-2030
... with a CAGR of 9.88% during the forecast period 2024-2030. The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with ... Read More
-
Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)
... has released a research report titled “Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)” which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market ... Read More
Research Assistance
